Mercer Global Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-14,198
| Closed | -$360K | – | 1961 |
|
|
2024
Q2 | $360K | Sell |
14,198
-73
| -0.5% | -$1.85K | ﹤0.01% | 1488 |
|
|
2024
Q1 | $441K | Buy |
14,271
+99
| +0.7% | +$3.06K | ﹤0.01% | 1346 |
|
|
2023
Q4 | $572K | Buy |
14,172
+59
| +0.4% | +$2.38K | ﹤0.01% | 1238 |
|
|
2023
Q3 | $372K | Hold |
14,113
| – | – | ﹤0.01% | 1404 |
|
|
2023
Q2 | $243K | Buy |
14,113
+3,613
| +34% | +$62.2K | ﹤0.01% | 1633 |
|
|
2023
Q1 | $174K | Sell |
10,500
-39
| -0.4% | -$646 | ﹤0.01% | 1757 |
|
|
2022
Q4 | $80K | Hold |
10,539
| – | – | ﹤0.01% | 1838 |
|
|
2022
Q3 | $105K | Buy |
+10,539
| New | +$105K | ﹤0.01% | 1713 |
|